Marfloquin 20 mg Tablets for Dogs
Marfloquin 20 mg Tablets for Dogs
Authorised
- Marbofloxacin
Product identification
Medicine name:
Marfloquin 20 mg Tablets for Dogs
MARFLOQUIN 20 MG COMPRIMES POUR CHIENS
Active substance:
- Marbofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Marbofloxacin20.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- box containing 100 tablets (10 blister)
- box containing 10 tablets (1 blister)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
- Krka-Farma d.o.o.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4518248 4/2012
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0322/002
Concerned member states:
-
Austria
-
Belgium
-
France
-
Germany
-
Greece
-
Netherlands
-
Portugal
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 22/12/2023
French (PDF)
Published on: 7/04/2022
How useful was this page?:
